Macular edema | Frontotemporal dementia

Treatment for macular edema has long-lasting gains; blood marker could track frontotemporal dementia; how breathing activates lung defenses

Having trouble viewing this email? View it as a Web page.

May 3, 2022 Edition

Color fundus photograph of an eye with retinal vein occlusion

Treatment for macular edema has long-lasting gains

A treatment for macular edema due to retinal vein occlusion yielded vision gains for at least five years, although many patients required ongoing treatment.

Doctor pointing to a computer screen explaining something to a patient

Blood marker shows potential for tracking frontotemporal dementia

Blood levels of a protein called NfL could help identify people with a brain disease called frontotemporal dementia, or FTD, even in its early stages.

How breathing activates lung defenses against viruses

Researchers used advanced tissue chip technology to learn how the physical forces of breathing help boost immunity in lung tissue.

Connect with us:

Facebook

RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

May 3, 2022 Edition

Treatment for macular edema has long-lasting gains

Blood marker shows potential for tracking frontotemporal dementia

How breathing activates lung defenses against viruses

Popular Stories:

Connect with us: